NHS to fund Afinitor for TSC-related epilepsy

2nd January 2019 Uncategorised 0

NHS England has announced that from April this year it will fund Novartis’ Afinitor (everolimus) for patients living with Tuberous Sclerosis Complex (TSC)-related refractory epilepsy.

More: NHS to fund Afinitor for TSC-related epilepsy
Source: News